Roberto Salvatori, MD

Unless otherwise indicated, this information has been self-reported and has not been verified by the Board of Medicine.

Johns Hopkins University School Of Medicine - Baltimore MD
Rank: Full Professor
Years: 2013-present

None Reported

More than a decade of real-world experience of pegvisomant for acromegaly: ACROSTUDY
Eur J Endocrinol
Volume: 185
Date: 08 2021

Advances in differential diagnosis and management of growth hormone deficiency in children
Nat Rev Endocrinol
Volume: 17
Date: 10 2021

Consensus on diagnosis and management of Cushing's disease: a guideline update
Lancet Diabetes Endocrinol
Volume: 9
Date: 12 2021

Speed of response to dopaminergic agents in prolactinomas
Endocrine
Volume: 75
Date: 03 2022

The biochemical diagnosis of acromegaly: revising the role of measurement of IGF-I and GH after glucose load in 5 questions
Expert Rev Endocrinol Metab
Volume: 17
Date: 05 2022

Patient-reported outcomes in patients with acromegaly treated with pegvisomant in the ACROSTUDY extension: A real-world experience
Pituitary
Volume: 25
Date: 06 2022

Levoketoconazole treatment in endogenous Cushing's syndrome: extended evaluation of clinical, biochemical, and radiologic outcomes
Eur J Endocrinol
Volume: 187
Date: 11 2022

Perioperative Evaluation and Management of Patients on Glucocorticoids
J Endocr Soc
Volume: 7
Date: 12 2022

Pituitary adenomas registry in Thailand
J Clin Neurosci
Volume: 115
Date: 09 2023
pubmed.ncbi.nlm.nih.gov/37572520/

Current role of pasireotide in the treatment of acromegaly
Best Pract Res Clin Endocrinol Metab
Date: 01 2024
pubmed.ncbi.nlm.nih.gov/38290866/